141
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Neutral endopeptidase and natriuretic peptide receptors participate in the regulation of C-type natriuretic peptide expression in renal interstitial fibrosis

, , , , , , , & show all
Pages 71-83 | Received 12 Nov 2015, Accepted 13 Feb 2016, Published online: 08 Jun 2016

References

  • Sudoh T, Minamino N, Kangawa K, et al. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun1990;168:863–70.
  • Stahl K, Stahl M, de Jonge HR, et al. ANP and CNP activate CFTR expressed in Xenopus laevis oocytes by direct activation of PKA. J Recept Signal Transduct Res 2015;35:493–504.
  • Johnson KR, Hoagland TM, Olson KR. Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout. J Exp Biol 2011;214:2709–17.
  • Hu P, Huang BY, Xia X, et al. Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway. J Recept Signal Transduct Res 2015;13:1–7.
  • Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol 2012;27:901–9.
  • Farris AB, Colvin RB. Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens 2012;21:289–300.
  • Hu P, Lu L, Hu B, et al. Renal action of C-type natriuretic peptide: advocating the isolated perfused rat kidney model. Saudi J Kidney Dis Transpl 2010;21:613–20.
  • Das S, Au E, Krazit ST, et al. Targeted disruption of guanylyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: role of proinflammatory cytokines. Endocrinology 2010;151:5841–50.
  • Canaan-Kühl S, Ostendorf T, Zander K, et al. C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 1998;53:1143–51.
  • Hu P, Wang J, Hu B, et al. Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis. Peptides 2012;37:98–105.
  • Nakanishi K, Tajima F, Itoh H, et al. Expression of C-type natriuretic peptide during development of rat lung. Am J Physiol 1999;277:L996–1002.
  • Grandclement B, Morel G. Ultrastructural characterization of atrial natriuretic peptide receptors (ANP-R) mRNA expression in rat kidney cortex. Biol Cell 1998;90:213–22.
  • Malfroy B, Schofield PR, Kuang WJ, et al. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem Biophys Res Commun 1987;144:59–66.
  • Kimura M, Asano M, Abe K, et al. Role of atrophic changes in proximal tubular cells in the peritubular deposition of type IV collagen in a rat renal ablation model. Nephrol Dial Transplant 2005;20:1559–65.
  • Cataliotti A, Giordano M, De Pascale E, et al. CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome. Am J Physiol Renal Physiol 2002;283:F464–72.
  • Bae EH, Kim SW. Upregulation of renin-angioteinsin, endothelin and C-type natriuretic peptide in rat glomerulus with bilateral ureteral obstruction. Korean J Physiol Pharmacol 2006;10:343–8.
  • Lee SJ, Kim SZ, Cui X, et al. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Am J Physiol Heart Circ Physiol 2000;278:H208–21.
  • Amantini C, Mosca M, Lucciarini R, et al. Thiorphan-induced survival and proliferation of rat thymocytes by activation of Akt/survivin pathway and inhibition of caspase-3 activity. J Pharmacol Exp Ther 2008;327:215–25.
  • Nagai Y, Miyata K, Sun GP, et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 2005;46:1039–45.
  • Qin YH, Lei FY, Hu P, et al. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol 2009;24:1477–86.
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–8.
  • Oldroyd SD, Thomas GL, Gabbiani G, et al. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int 1999;56:2116–27.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
  • Zhou TB, Qin YH, Zhou C, et al. Less expression of prohibitin is associated with increased caspase-3 expression and cell apoptosis in renal interstitial fibrosis rats. Nephrology (Carlton) 2012;17:189–96.
  • Zhou TB, Qin YH, Li ZY, et al. All-trans retinoic Acid treatment is associated with prohibitin expression in renal interstitial fibrosis rats. Int J Mol Sci 2012;13:2769–82.
  • Zhou TB, Zeng ZY, Qin YH, et al. Less expression of prohibitin is associated with increased paired box 2 (PAX2) in renal interstitial fibrosis rats. Int J Mol Sci 2012;13:9808–25.
  • Chevalier RL. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol 1999;13:612–9.
  • Chevalier RL, Thornhill BA, Wolstenholme JT. Renal cellular response to ureteral obstruction: role of maturation and angiotensin II. Am J Physiol 1999;277:F41–7.
  • Picard N, Baum O, Vogetseder A, et al. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 2008;130:141–55.
  • Ogata Y, Ishidoya S, Fukuzaki A, et al. Upregulated expression of transforming growth factor-beta, type IV collagen, and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction. Tohoku J Exp Med 2002;197:159–68.
  • Xie P, Sun L, Nayak B, et al. C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. J Am Soc Nephrol 2009;20:807–19.
  • Hu P, Qin YH, Pei J, et al. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril. Exp Mol Pathol 2010;89:51–7.
  • Ahluwalia A, MacAllister RJ, Hobbs AJ. Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res Cardiol 2004;99:83–9.
  • Kim SW, Li Y, Kim S, et al. Local renal and vascular natriuretic peptide system in obstructive uropathic rats. Urol Res 2002;30:97–101.
  • Surendran K, Simon TC. CNP gene expression is activated by Wnt signaling and correlates with Wnt4 expression during renal injury. Am J Physiol Renal Physiol 2003;284:F653–62.
  • Woodard GE, Rosado JA. Recent advances in natriuretic peptide research. J Cell Mol Med 2007;11:1263–71.
  • Chauhan SD, Nilsson H, Ahluwalia A, et al. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci USA 2003;100:1426–31.
  • Hu P, Wang J, Zhao XQ, et al. Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats. Mol Biol Rep 2013;40:1429–41.
  • Koller KJ, Lowe DG, Bennett GL, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 1991;252:120–3.
  • Sellitti DF, Koles N, Mendonca MC. Regulation of C-type natriuretic peptide expression. Peptides 2011;32:1964–71.
  • Lohe A, Yeh I, Hyver T, et al. Natriuretic peptide B receptor and C-type natriuretic peptide in the rat kidney. J Am Soc Nephrol 1995;6:1552–8.
  • Doi K, Ikeda T, Itoh H, et al. C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol 2001;21:930–6.
  • Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006;27:47–72.
  • Kramer HJ, Bäcker A, Bokemeyer D, et al. Atrial natriuretic peptide and endothelin: modulators of renal function. Clin Investig 1994;72:703–5.
  • Rose RA, Giles WR. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol (Lond) 2008;586:353–66.
  • Woodard GE, Li X, Rosado JA. Characteristics of the renal C-type natriuretic peptide receptor in hypertrophied and developing rat kidney. J Mol Endocrinol 2005;35:519–30.
  • Nagase M, Ando K, Katafuchi T, et al. Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats. Hypertension 1997;30:177–83.
  • Sumitomo M, Shen R, Nanus DM. Involvement of neutral endopeptidase in neoplastic progression. Biochim Biophys Acta 2005;1751:52–9.
  • Jalal F, Lemay G, Zollinger M, et al. Neutral endopeptidase, a major brush border protein of the kidney proximal nephron, is directly targeted to the apical domain when expressed in Madin-Darby canine kidney cells. J Biol Chem 1991;266:1926–32.
  • Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis with vascular injury induced by anti-neutral endopeptidase antibodies: toward new concepts in the pathogenesis of glomerular diseases. J Am Soc Nephrol 2003;14:S27–S32.
  • Hu P, Xuan Q, Hu B, et al. Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy. Mol Biol Rep 2013;40:2963–7.
  • Floras JS. Vasopeptidase inhibition: a novel approach to cardiovascular therapy. Can J Cardiol 2002;18:177–82.
  • Nakhoul F, Ramadan R, Khankin E, et al. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies. Am J Physiol Renal Physiol 2005;289:F880–90.
  • Wenzel UO, Wolf G, Jacob I, et al. Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats. Nephrol Dial Transplant 2003;18:2005–13.
  • Hu P, Zhang XC, Kong HB, et al. Exogenous C-type natriuretic peptide infusion ameliorates unilateral ureteral obstruction-induced tubulointerstitial fibrosis in rats. Lab Invest 2015;95:263–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.